Skip to content
healthcare.dev

GLYCOPHOS

NDC 65219-346, Sodium Glycerophosphate, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
65219-346
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA220381
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-346 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM GLYCEROPHOSPHATE ANHYDROUS216 mg/mL
Package NDCNDC-11Package
65219-346-206521903462025 VIAL, SINGLE-DOSE in 1 CARTON (65219-346-20) / 20 mL in 1 VIAL, SINGLE-DOSE (65219-346-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e887e473-f1a7-40f1-bd6e-c99e7db7420d

Use it

Look up 65219-346 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-346 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-346. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.